Image For Activity Cover
Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation - JCEP December 2022
Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation - JCEP December 2022

Our data support the current recommendation to initiate pill-in-the-pocket (PIP) antiarrhythmic drugs (AAD) in a monitored setting because of rare significant adverse reactions that can require urgent intervention.


Editor-in-Chief
Kalyanam Shivkumar, MD, PhD, FACC 

CME Editor
Kenneth A. Ellenbogen, MD, FACC

Author
Mahmoud Houmsse, MD, FACC

Important Dates
Date of Release: December 19, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: December 18, 2023
Summary
Availability: On-Demand
Expires on Dec 18, 2023
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By